VP or Director, Healthcare M&A Strategy – NYC

Our client, a global leader in healthcare investment banking has created a new role on their M&A team and has engaged Tal Sharon Enterprises to help develop and fill this role.

VP or Director, Healthcare M&A Strategy – NYC

Responsibilities:
This newly created position will report to the MD, Head of M&A, Healthcare Banking and work with members or the M&A and Equity Research teams.  The ideal candidate will be a successful senior strategy consultant that is looking to transition to M&A/ Deal-side experience.  This candidate will be a key part of the development of materials, present to the senior leadership of our clients and begin to lead their own deals from sourcing to execution.
Our clients include some of the most exciting and innovative biotechs as well as top 20 pharma.
Provide Commercial and Scientific Assessments to our Investment Banking team.
Assist in the origination and execution of M&A and advisory transactions
 Oversee the development of initial pitch books and transactional written materials related to the origination and execution of M&A transactions, private financings, valuations and fairness opinions
Lead Strategy and Diligence sessions for our clients
Provide recommendations to internal M&A team as well as Client leadership (BD, M&A, C level)
Create and Work with Research Analysts to develop reports and decks

Requirements:

  • 8+ years of Strategy Consulting, Management Consulting, BD&L or similar experience
  • Strong background in the biological sciences with a Masters’ degree or PhD, MD preferred
  • MBA from top-tier B school
  • Outstanding interpersonal and written communication skills
  • A strong competitive spirit balanced by a proven ability to work as part of a team

qualified candidates should email resume to jobs@tseworldwide.com

Author: TSEWORLDWIDE

Michael is a 1996 graduate from Rutgers, The State University of NJ where he majored in Political Science. After Rutgers, Michael spent a year in Israel studying and working with early stage tech companies. After returning to the US, Michael spent 5 years with The Princeton Review in Operations of their graduate level courses. In 2001, Michael joined a staffing company where he led his office in sales of IT consulting services. In 2003, Michael started TSE and quickly found a niche in Strategy Consulting. He has formed partnerships with some of the leading consultancies in the areas of portfolio strategy, commercial assessment, market assess, payer strategy and operational effectiveness. Michael has helped consultancies and client side companies make key hires. In addition to recruiting, Michael helped Rutgers University create their Center for Innovative Ventures of Emerging Technologies and served as an Entrepreneur-in-Residence and Sounding Board Member for 5 years. He continues to stay active in the field of higher learning helping students of the sciences think about careers in the pharmaceutical industry.